Marijuana Impairment
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Marijuana Impairment trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Marijuana Impairment trials you may qualify forThis study is designed to evaluate an integrated intervention to reduce alcohol and marijuana use and consequences and improve sleep among young adults with com…
The goal of this clinical trial is to evaluate whether in-vehicle sensor data can be used to detect cannabis-impaired driving in healthy adult recreational cann…
This human laboratory study will use cognitive, behavioral, and subjective measures to characterize impairment associated with co-use of alcohol and vaporized c…
The prevalence of major depressive disorder (MDD) is \~5.0%, and rates of co-occurring SUDs in these patients approach 40-50%. Specifically, rates of co-morbid…
This is a double-blind, randomized controlled trial designed to test the effects of cannabidiol (CBD) on validated biomarkers of Alzheimer's disease (AD) progre…
Cognitive impairment is well established in people with psychosis and is associated with cannabis use. The current study will investigate the neurobiological ba…
Researchers at the University of Colorado Anschutz Medical Campus, Colorado School of Public Health, and Injury \& Violence Prevention Center want to learn more…
The goal of this interventional study is to determine the impact of high potency THC product use on cognitive function of young adults aged 21-25. The main que…
The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of inhaled cannabis with varying amounts of delta-9-tetrahydrocannabinol (TH…